60 Degrees Pharmaceuticals, Inc. - Common Stock (SXTP)
0.5290
+0.0173 (3.38%)
60 Degrees Pharmaceuticals, Inc. is a biopharmaceutical company focused on developing and commercializing innovative treatments to address unmet medical needs
The company is particularly dedicated to creating novel therapeutics for infectious diseases, with an emphasis on leveraging advanced drug delivery systems to improve patient outcomes and enhance the efficacy of existing treatment paradigms. By conducting research and clinical trials, 60 Degrees Pharmaceuticals aims to bring transformative therapies to market that can significantly alter the course of disease treatment and management for patients worldwide.